Not applicableUnknownNCT03363880What this trial is testingEstablishment of Regional Severe Trauma Management SystemWho this might be right forTraumaMultiple TraumaEmergencies Peking University People's Hospital 7,250
Not applicableStudy completedNCT05576779What this trial is testingCharacterization of Early Patients Initiating Ofatumumab for Treatment of Multiple Sclerosis.Who this might be right forMultiple Sclerosis Novartis Pharmaceuticals 2,101
Not applicableLooking for participantsNCT07358910What this trial is testingRisk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveWho this might be right forDengueChikungunyaZika Virus Infection+55 more Institut Pasteur du Cambodge 10,000
Early research (Phase 1)Ended earlyNCT02931110What this trial is testingStudy of IV CBL0137 in Previously Treated Hematological SubjectsWho this might be right forHematological Malignancies Incuron 5
Early research (Phase 1)Study completedNCT00274742What this trial is testingSafety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHLWho this might be right forNon-Hodgkin's Lymphoma, Relapsed Amgen Research (Munich) GmbH 76
Large-scale testing (Phase 3)UnknownNCT03553238What this trial is testingPrecision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALLWho this might be right forLeukemia, AcuteLeukemia, T CellLeukemia, Lymphoblastic Nanfang Hospital, Southern Medical University 70
Early research (Phase 1)Looking for participantsNCT06569758What this trial is testingGenSci098 in Subjects With Active Thyroid Eye DiseaseWho this might be right forSafetyTolerabilityGenSci098+1 more Changchun GeneScience Pharmaceutical Co., Ltd. 76
Large-scale testing (Phase 3)Ended earlyNCT01163253What this trial is testingA Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Pfizer 2,867
Testing effectiveness (Phase 2)Study completedNCT03780257What this trial is testingStudy to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A GeneWho this might be right forRetinitis PigmentosaUsher Syndrome Type 2Deaf Blind+5 more ProQR Therapeutics 20
Early research (Phase 1)Ended earlyNCT03486067What this trial is testingStudy of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Participants With Relapsed and Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Celgene 183
Testing effectiveness (Phase 2)Study completedNCT00024466What this trial is testingChemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple MyelomaWho this might be right forMultiple Myeloma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 28
Large-scale testing (Phase 3)Not Yet RecruitingNCT07635953What this trial is testingNew Triple Combination Therapy in Newly Diagnosed Type 2 DiabetesWho this might be right forDiabetes Mellitus Sun Yat-sen University 296
Large-scale testing (Phase 3)Study completedNCT01082367What this trial is testingRandomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 YearsWho this might be right forTreatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis Patients Novartis Pharmaceuticals 50
Large-scale testing (Phase 3)Study completedNCT04677972What this trial is testingSPI-1005 for the Treatment of Meniere's DiseaseWho this might be right forMeniere DiseaseMénière Sound Pharmaceuticals, Incorporated 220
Not applicableLooking for participantsNCT07492667What this trial is testingComparison of the Performance of the 2024 and 2017 McDonald Criteria for the Diagnosis of Multiple Sclerosis in Real LifeWho this might be right forEvent Suggestive of Multiple SclerosisMultiple Sclerosis Central Hospital, Nancy, France 100
Early research (Phase 1)Not Yet RecruitingNCT06900192What this trial is testingAllogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple SclerosisWho this might be right forPrimary Progressive Multiple SclerosisMultiple SclerosisMultiple Sclerosis, Primary Progressive+1 more Stanford University 10
Not applicableActive Not RecruitingNCT04012944What this trial is testingSIRONA 2 Trial Heart Failure NYHA Class IIIWho this might be right forHeart Failure NYHA Class III Endotronix, Inc. 81
Not applicableLooking for participantsNCT05259553What this trial is testingBiomarkers in Multiple MyelomaWho this might be right forHematological PatientsNewly Diagnosed Multiple MyelomaChemotherapy Centre Hospitalier Universitaire de Saint Etienne 70
Testing effectiveness (Phase 2)Ended earlyNCT02294357What this trial is testingWeekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 CarfilzomibWho this might be right forMultiple Myeloma Oncotherapeutics 45
Not applicableUnknownNCT03121430What this trial is testingStudy of Drug Eluting Peripheral Vascular Stent System in Superficial Femoral Artery Stenosis and /or OcclusionWho this might be right forPeripheral Arterial DiseaseSuperficial Femoral Artery StenosisSuperficial Femoral Artery Occlusion Zhejiang Zylox Medical Device Co., Ltd. 138